Medication Comparison

Xanax vs. Ativan: Differences Between Alprazolam and Lorazepam

Two of the most commonly prescribed benzodiazepines in the United States look similar on paper — but their onset, duration, metabolism, and withdrawal profiles differ in ways that matter clinically.

Published: July 24, 2026
7 min read
BZ

Written by

Benjamin Zohar, NCACIP

Nationally Certified Advanced Clinical Intervention Professional

EZ

Edited by

Ezra Zohar, M.S. Ed.

Editorial Director

BM

Medically Reviewed by

Brandon McNally, RN

Medical Reviewer, ICU Critical Care Nurse

Published: July 24, 2026
7 min read

Key takeaways

  • Same class, different profiles. Xanax (alprazolam) and Ativan (lorazepam) are both benzodiazepines that enhance GABA activity, but differ meaningfully in speed and duration.
  • Xanax is faster and more potent; Ativan is slower to start but generally lasts longer.
  • Ativan bypasses CYP450 metabolism, which is why it is often preferred in older adults and people with liver disease.
  • Both carry dependence and withdrawal risk. Xanax's shorter half-life is associated with sharper rebound and more abrupt withdrawal.
  • Guidelines favor SSRIs/SNRIs + CBT as first-line, long-term treatment for anxiety disorders.

Xanax and Ativan get lumped together in casual conversation, and it is easy to see why: both are benzodiazepines, both reduce anxiety, and both are prescribed for many of the same reasons. In the families I work with on Long Island, the question that comes up over and over is a version of "aren't these basically the same thing?" Clinically, they aren't. The differences show up most clearly in how quickly the drug takes hold, how long it lasts, how the body clears it, and — importantly — what happens when someone tries to stop.

What Xanax and Ativan have in common

Alprazolam (Xanax) and lorazepam (Ativan) both belong to the benzodiazepine class. They work by enhancing the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors in the brain, which calms overactive neural signaling. That mechanism produces the anxiolytic, sedative, muscle-relaxant, and anticonvulsant effects the whole drug class shares. According to a widely cited pharmacology review in The Ochsner Journal, this is why benzodiazepines are used across such a wide range of indications — from generalized anxiety and panic disorder to alcohol withdrawal, procedural sedation, and status epilepticus. For a broader look at how these two medications compare to another commonly prescribed benzodiazepine, see the International Society of Substance Use Professionals overview of Xanax, Ativan and Klonopin differences.

Pharmacology at a glance

The table below summarizes the differences most likely to matter in prescribing decisions. All figures reference the FDA prescribing information for each drug.

PropertyXanax (alprazolam)Ativan (lorazepam)
Drug classShort-acting benzodiazepineIntermediate-acting benzodiazepine
Onset of action (oral)~15–30 minutes~30–60 minutes
Elimination half-life~11 hours (adults)~10–20 hours
Duration of clinical effect~4–6 hours (immediate release)~6–8 hours
MetabolismHepatic (CYP3A4) with active metabolitesGlucuronidation — no clinically active metabolites
Approximate equivalent dose0.5 mg1 mg
Common FDA-labeled usesGeneralized anxiety disorder, panic disorderAnxiety disorders, preoperative sedation, status epilepticus (IV)
DEA scheduleSchedule IVSchedule IV

Onset and duration: why the difference matters

Xanax's faster onset is the main reason it is often prescribed for panic disorder — when someone is already in the middle of a panic attack, a drug that begins working within 15 to 30 minutes feels dramatically different from one that takes closer to an hour. That same speed, though, is a double-edged sword: the effect fades faster, which is why alprazolam is typically dosed three times daily and why some people describe a noticeable "wearing off" between doses. Ativan's slower ramp and longer tail tend to produce a smoother, more even effect, which is often preferred for generalized anxiety, hospital-based sedation, and situations where consistency matters more than speed.

Metabolism: the geriatric and liver-disease question

This is where the two drugs genuinely diverge. Alprazolam is metabolized primarily by CYP3A4 in the liver and produces active metabolites, which means its effects can be prolonged by medications that inhibit CYP3A4 (some antifungals, macrolide antibiotics, and HIV protease inhibitors, among others) and by hepatic impairment. Lorazepam, on the other hand, is metabolized by glucuronidation — a Phase II pathway that is largely preserved in older adults and in people with liver disease — and has no clinically active metabolites. That is why, alongside oxazepam and temazepam, lorazepam is often referred to as a "LOT" benzodiazepine and is generally preferred when hepatic reserve is limited or CYP interactions are a concern.

Dependence, tolerance, and withdrawal

Both alprazolam and lorazepam can produce physical dependence — the body's adaptation to regular exposure — within weeks of daily use, and both can produce severe withdrawal on abrupt discontinuation, including seizures. The clinically important difference is that shorter half-lives tend to produce sharper, faster-onset withdrawal, and alprazolam is one of the shorter-acting benzodiazepines in common outpatient use. In practice, that means:

  • Interdose rebound anxiety is more common with Xanax than with Ativan.
  • Missing a scheduled Xanax dose can trigger early withdrawal symptoms within hours.
  • Tapers off alprazolam are often stabilized by first switching to a longer-acting benzodiazepine (commonly diazepam) to smooth the withdrawal curve.

Neither drug should be stopped abruptly after regular use. For a full walk-through of how benzodiazepine withdrawal unfolds, see our benzo withdrawal timeline and our detailed guide to benzodiazepine addiction treatment on Long Island.

Interactions and overdose risk

The most dangerous interactions for both drugs are with other central nervous system depressants: opioids, alcohol, other benzodiazepines, gabapentinoids, sedating antihistamines, and z-drugs like zolpidem. The National Institute on Drug Abuse has repeatedly flagged benzodiazepine-plus-opioid combinations as a leading driver of overdose deaths in the United States. Alprazolam has a specific additional wrinkle: because it depends on CYP3A4, inhibitors of that enzyme can raise its levels substantially, which is one reason the prescribing label carries specific warnings about grapefruit juice and several common medications.

When clinicians consider alternatives

For long-term treatment of anxiety disorders, most modern guidelines — including the American Psychiatric Association's practice guideline for panic disorder and the VA/DoD PTSD guideline — favor SSRIs or SNRIs combined with cognitive behavioral therapy. Benzodiazepines like Xanax and Ativan are more appropriate for short-term relief, breakthrough symptoms, procedural sedation, or specific clinical situations where the trade-offs make sense. The point is not that benzodiazepines are always the wrong choice; the point is that "just keep taking them" is rarely the plan a careful clinician would land on for chronic anxiety.

Getting help on Long Island

If daily Xanax or Ativan use has slipped past what a prescriber originally intended — early withdrawal between doses, escalating amounts, using someone else's supply, or mixing with alcohol or opioids — that is worth taking seriously. Because benzodiazepine withdrawal can be medically dangerous, the safest first step is almost always medically supervised detox, followed by the right level of care. You can also read our substance-specific guides to Xanax addiction and Ativan addiction, or our comprehensive resource on benzodiazepine addiction treatment on Long Island.

Our 24/7 confidential helpline is 844-338-6969.

Frequently Asked Questions

Get answers to common questions about our 24/7 crisis helpline and addiction support services.

Still have questions? Our crisis counselors are available 24/7.

Call 844-338-6969

About the author

Benjamin Zohar, NCACIP is a Nationally Certified Advanced Clinical Intervention Professional with more than a decade of experience in structured family intervention and clinical placement across New York State. This article was edited by Ezra Zohar, M.S. Ed., and medically reviewed for clinical accuracy by Brandon McNally, RN, an ICU critical care nurse.

Medical References & Sources

This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.

  1. U.S. Food and Drug Administration. "XANAX (alprazolam) — Prescribing Information." DailyMed / FDA Label. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1015ee4-fed7-4d8b-a129-d95d1f70c93b
  2. U.S. Food and Drug Administration. "ATIVAN (lorazepam) — Prescribing Information." DailyMed / FDA Label. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c48ca179-a798-4907-b6b9-1c8e33f43286
  3. Griffin CE, Kaye AM, Bueno FR, Kaye AD. "Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects." The Ochsner Journal, 2013. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3684331/
  4. American Psychiatric Association. "Practice Guideline for the Treatment of Patients With Panic Disorder." APA. Available at: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf
  5. Department of Veterans Affairs / Department of Defense. "VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder.", 2023. Available at: https://www.healthquality.va.gov/guidelines/MH/ptsd/
  6. Ashton CH. "Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual).", 2002. Available at: https://www.benzo.org.uk/manual/
  7. National Institute on Drug Abuse. "Benzodiazepines and Opioids.". Available at: https://nida.nih.gov/research-topics/opioids/benzodiazepines-opioids

Medical Disclaimer

The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.

This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: July 24, 2026.

If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 844-338-6969 for free, confidential information and treatment referral.

Disclaimer: This article is for educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Never start, stop, switch, or combine benzodiazepines without consulting a qualified healthcare provider. If you are experiencing a medical emergency, call 911.

Related Resources